Krebs Biochemicals & Industries
Krebs Biochemicals & Industries Share Price Chart
Krebs Biochemicals & Industries last traded at ₹55.94 (2026-10-13). Over the past month the stock moved -9.0%, three months the stock moved -10.2%, year the stock moved -28.6%. Its closing range over 52 weeks is ₹43.63 – ₹71.00, with the latest close 21.2% below the high.
Closing prices up to 2026-10-13.
About Krebs Biochemicals & Industries
Incorporated in 1991, Krebs Biochemicals & Industries Ltd is presently engaged in manufacturing of active pharmaceutical ingredients.
Business Overview:[1] KBIL is engaged in the business of manufacture of active pharmaceutical ingredients.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Krebs Biochemicals & Industries reported sales of ₹6.98 crore (+27.4%) and net profit of ₹-2.48 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 6.98 | 0.82 | 11.75 | -2.48 | -1.15 |
| Mar 2026 | 6.81 | -0.86 | -12.63 | -2.34 | -1.09 |
| Dec 2025 | 7.27 | 0.30 | 4.13 | -3.13 | -1.45 |
| Sep 2025 | 4.17 | -2.80 | -67.15 | -6.14 | -2.85 |
| Jun 2025 | 5.48 | -2.09 | -38.14 | -5.32 | -2.47 |
| Mar 2025 | 6.10 | -5.41 | -88.69 | -8.27 | -3.84 |
| Dec 2024 | 11.47 | -4.71 | -41.06 | -7.74 | -3.59 |
| Sep 2024 | 12.86 | -2.72 | -21.15 | -5.76 | -2.67 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -13.6% | -11.6% | -49.0% | -57.5% | -67.6% | -36.6% | +11.6% | +27.4% |
| Operating profit growth | – | – | – | – | – | – | – | – |
| Net profit growth | – | – | – | – | – | – | – | – |
| EPS growth | – | – | – | – | – | – | – | – |
| OPM % | -21.2% | -41.1% | -88.7% | -38.1% | -67.2% | 4.1% | -12.6% | 11.8% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Krebs Biochemicals & Industries reported sales of ₹24.00 crore (-44.2%) and net profit of ₹-17.00 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 24.00 | -5.00 | -23.00 | -17.00 | -7.85 |
| Mar 2025 | 43.00 | -15.00 | -35.00 | -27.00 | -12.50 |
| Mar 2024 | 50.00 | -9.00 | -17.00 | -20.00 | -9.15 |
| Mar 2023 | 52.00 | -16.00 | -30.00 | -25.00 | -11.45 |
| Mar 2022 | 60.00 | -34.00 | -57.00 | -45.00 | -20.65 |
| Mar 2021 | 54.00 | -18.00 | -33.00 | -28.00 | -14.45 |
| Mar 2020 | 33.00 | -19.00 | -56.00 | -29.00 | -16.04 |
| Mar 2019 | 48.00 | -10.00 | -20.00 | -20.00 | -12.03 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +41.2% | -31.3% | +63.6% | +11.1% | -13.3% | -3.8% | -14.0% | -44.2% |
| Operating profit growth | – | – | – | – | – | – | – | – |
| Net profit growth | – | – | – | – | – | – | – | – |
| EPS growth | – | – | – | – | – | – | – | – |
| OPM % | -20.0% | -56.0% | -33.0% | -57.0% | -30.0% | -17.0% | -35.0% | -23.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Krebs Biochemicals & Industries.
Get Free AI Stock Analysis FREE →Latest News
-
Krebs Biochemicals holds 34th AGM, approves reappointments and RPTs - scanx.trade
-
Krebs Biochemicals & Industries Board Meeting Scheduled for May 21, 2026 to Approve Q4 and FY26 Financial Results - scanx.trade
-
Krebs Biochemicals & Industries Board Meeting Scheduled for May 21, 2026 to Approve Q4 and FY26 Financial Results - scanx.trade
-
Krebs Biochemicals & Industries Board Meeting Scheduled for May 21, 2026 to Approve Q4 and FY26 Financial Results - scanx.trade
-
Krebs Biochemicals & Industries Board Meeting Scheduled for May 21, 2026 to Approve Q4 and FY26 Financial Results - scanx.trade
-
Krebs Biochemicals & Industries Ltd leads gainers in 'B' group - Business Standard
Frequently Asked Questions
What is Krebs Biochemicals & Industries's current stock price?
Krebs Biochemicals & Industries shares were last quoted at ₹55.94 (-0.1% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Krebs Biochemicals & Industries?
Krebs Biochemicals & Industries has a price-to-earnings (P/E) ratio of -8.64 and a price-to-book (P/B) ratio of 0.00. The industry P/E is 52.82.
What is the 52-week high and low of Krebs Biochemicals & Industries?
The 52-week high of Krebs Biochemicals & Industries is ₹76.72 and the 52-week low is ₹38.52.
What is the market cap of Krebs Biochemicals & Industries?
The market capitalisation of Krebs Biochemicals & Industries is about ₹121.84 crore.
How did Krebs Biochemicals & Industries perform in its latest quarterly results?
In the latest quarter (Jun 2026), Krebs Biochemicals & Industries reported sales of ₹6.98 crore (+27.4%) and net profit of ₹-2.48 crore, compared with the same quarter last year.
Is Krebs Biochemicals & Industries a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Krebs Biochemicals & Industries has 3-year profit growth of 10.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Krebs Biochemicals & Industries?
Promoters hold about 72.74% of Krebs Biochemicals & Industries.
Which sector does Krebs Biochemicals & Industries belong to?
Krebs Biochemicals & Industries belongs to the Pharmaceuticals & Drugs sector.